Search results
Results from the WOW.Com Content Network
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; [2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.
23andMe CEO Anne Wojcicki co-founded the company in 2006 with biologist Linda Avey and Paul Cusenza, who previously worked at the now-defunct Perlegen Sciences, which was a biotech startup that ...
In March 2006 Avey, Anne Wojcicki, and Paul Cusenza founded 23andMe, [8] [9] [10] "one of the first, and only, [clarification needed] companies to offer genetic profiles directly to consumers, rather than through doctors or researchers". [11] Avey left the company in 2009. [12] Cusenza had left the company in 2007. [citation needed]
(Reuters) - Genetic testing firm 23andMe Chief Executive Officer Anne Wojcicki would no longer be open to considering third-party takeover proposals for the company, a regulatory filing showed on ...
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
In October 2023, Wired reported that a sample of data points from 23andMe accounts were exposed on BreachForums, a black-hat hacking crime forum. [1]23andMe confirmed to TechCrunch that because of an opt-in feature that allows DNA-related relatives to contact each other, the true number of people exposed was 6.9 million, nearly half of 23andMe’s 14 million reported customers.
(Reuters) - 23andMe will pay $30 million and provide three years of security monitoring to settle a lawsuit accusing the genetics testing company of failing to protect the privacy of 6.9 million ...